Cargando…
Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
Autores principales: | Vedvyas, Yogindra, McCloskey, Jaclyn E., Yang, Yanping, Min, Irene M., Fahey, Thomas J., Zarnegar, Rasa, Hsu, Yen-Michael S., Hsu, Jing-Mei, van Basien, Koen, Gaudet, Ian, Law, Ping, Kim, Nak Joon, von Hofe, Eric, Jin, Moonsoo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385653/ https://www.ncbi.nlm.nih.gov/pubmed/32719389 http://dx.doi.org/10.1038/s41598-020-69586-8 |
Ejemplares similares
-
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
por: Vedvyas, Yogindra, et al.
Publicado: (2019) -
SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
por: Alcaina, Yago, et al.
Publicado: (2022) -
Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity
por: Park, Spencer, et al.
Publicado: (2017) -
Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
por: Jung, Minkyu, et al.
Publicado: (2020) -
Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models
por: Yang, Yanping, et al.
Publicado: (2023)